Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Alexion Reports Failed Soliris Trial

Grappling with allegations of improper sales practices, Alexion Pharmaceuticals has announced a failure of a Phase II/III trial for expanded use of Soliris.

Read More »

Opexa Stock Tanks After Failed MS Trial, Cuts Staff

In the wake of a failed Phase IIb clinical trial, Opexa Therapeutics announced it will be laying off about 40 percent of its workforce.

Read More »

Merrimack CEO Resigns, Company Slashes Jobs

Robert Mulroy, CEO of Merrimack Pharmaceuticals, has resigned his position as part of a corporate restructuring move that will result in a 22 percent workforce reduction.

Read More »

Perrigo Names New CEO as Joseph Papa Joins Rival Valeant

April 25, 2016 By Alex Keown, Breaking News Staff     DUBLIN — John T. Hendrickson has been tapped as the new chief executive officer of Perrigo Company PLC (PRGO), after former CEO Joseph Papa left the company to helm rival Valeant Pharmaceuticals (VRX). Last week BioSpace (DHX) reported Papa was the favorite to […]

Read More »

Array BioPharma’s New CFO to Step Down After Just Three Months on the Job

BOIULDER, Colo. – After three months on the job, Array BioPharma, Inc. (ARRY)’s Chief Financial Officer Patricia Henahan is resigning her position, the company disclosed in a federal filing. Henahan’s last day is set for Dec. 17, four months and nine days after assuming her post with the company. Array disclosed the job change in […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom